Related Experiment Video
Updated: Jun 27, 2025
04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
7.4K
Association between Statin Use and Chemotherapy-Induced Cardiotoxicity: A Meta-Analysis
Vikash Jaiswal1, Song Peng Ang2, Novonil Deb3
1Department of Cardiovascular Research, Larkin Community Hospital, South Miami, FL 33143, USA.
Medicina (Kaunas, Lithuania)
|April 27, 2024
Summary
Statins may protect against chemotherapy-induced cardiac dysfunction (CIC). This meta-analysis found statin use improved left ventricular function and reduced heart failure risk in cancer patients undergoing chemotherapy.
Area of Science:
- Cardiology
- Oncology
- Pharmacology
Background:
- Chemotherapy-induced cardiac dysfunction (CIC) is a serious concern for cancer patients.
- Statins are known for cardiovascular benefits, but their role in preventing CIC is unclear.
Purpose of the Study:
- To evaluate the cardioprotective effects of statins in patients experiencing CIC.
- This meta-analysis synthesized evidence on statin use and cardiac outcomes in chemotherapy patients.
Main Methods:
- Systematic literature search of PubMed, Embase, and Scopus databases up to May 2023.
- Meta-analysis of nine studies with 5532 patients (1904 statin group, 3628 non-statin group).
- Outcomes assessed using pooled odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CIs).
Main Results:
- Statin use was associated with a smaller decline in left ventricular ejection fraction (LVEF) after chemotherapy (MD, 3.55).
- Higher final mean LVEF was observed in the statin group (MD, 2.08).
- Statin users had a significantly lower risk of developing heart failure (OR, 0.41).
Conclusions:
- Statin use demonstrates cardioprotective benefits in patients with CIC.
- Statins improve left ventricular function and decrease heart failure incidence.
- Further research may solidify statin's role in mitigating chemotherapy-related cardiac complications.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
198
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
198
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160
01:26Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
272
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
272